Skip to content
Search

Latest Stories

Community pharmacy deeply saddened as Queen Elizabeth dies at 96, ending an era for Britain

Queen Elizabeth II, Britain's longest-reigning monarch, the nation's figurehead and a towering presence on the world stage for seven decades, died peacefully at her home in Scotland on Thursday aged 96.

"The death of my beloved Mother, Her Majesty The Queen, is a moment of the greatest sadness for me and all members of my family," the new king, her eldest son Charles, said.


"I know her loss will be deeply felt throughout the country, the Realms and the Commonwealth, and by countless people around the world," the 73-year-old said in a statement.

The news has stunned and deeply saddened community pharmacy in Britain.

The Pharmaceutical Services Negotiating Committee (PSNC) issued a statement to say it "has been very saddened to hear of the death of Her Majesty the Queen.

"At this time of national mourning, we join the rest of the country in sending our thoughts and condolences to the royal family."

The board and staff of the National Pharmacy Association (NPA) "are very saddened at the news of the death of Her Majesty the Queen, after her long service to the nation. She was truly a towering figure in our nation and around the world."

The NPA paid tribute to King Charles III, who recently welcomed hundreds of pharmacists into Clarence House to recognise the association's centenary celebrations and work of community pharmacists up and down the country.

"Out of respect for The Queen and her family in mourning, we are postponing our national conference, scheduled for next week," the NPA chair, Andrew Lane, said in a statement on Friday (September 9).

"In line with protocol, we will minimise public NPA events, unless essential, for the period of mourning until after the funeral. We will continue to provide comprehensive support to help our members in the vital work they do; our advice lines and support services remain open as usual."

In a statement, the Royal Pharmaceutical Society (RPS) said the death of its patron "will be deeply felt by pharmacists and the whole pharmacy family. RPS president Professor Claire Anderson will write to the royal family to express sincere condolences from the RPS."

The General Pharmaceutical Council paid tribute to the Queen’s long and dedicated service to the country.

It stated: "It is with great sadness that we have learnt of the death of Her Majesty the Queen. Our thoughts and sympathies are with the royal family."

In a tweet, the newly appointed health secretary, Thérèse Coffey, mourned the death of the monarch.

Northern Ireland's health minister Robin Swann said: “My thoughts are first and foremost with her family at this time, as they grieve the loss of a mother, grandmother and great grandmother.

“This is a very sad and moving day, as we reflect on an incredible life of service, dignity and integrity."

Eluned Morgan, the health minister of Wales, thanked the Queen for her "selfless service and reassuring presence throughout decades of change."

"You will be sorely missed Ma'am."

Scotland's health minister Humza Yousaf said: "The Queen demonstrated a lifelong commitment to public service, carrying out her duties right to the very end of her life. My thoughts, prayers and condolences to members of the Royal Family and those who were closest to Her Majesty."

In a statement, Amanda Pritchard, chief executive of NHS England, wrote: "I know I speak on behalf of the whole NHS when I say how incredibly saddened we are by the news Her Majesty The Queen has passed away.

"The Queen dedicated her life to public service and it was our proudest moment when she awarded NHS staff the George Cross earlier this year, for their compassion and courage over the last 74 years but particularly during the pandemic.

"My heartfelt condolences are with the royal family at this time."

Chief executive of the North East London LPC, Shilpa Shah, took to twitter to express her sense of loss at the death of the monarch.

https://twitter.com/ShilpaS76/status/1567992139061104641

Day Lewis Pharmacy took to Twitter to express the group's sadness.

Chief executive of the Association of British Pharmaceutical Industry (ABPI) Richard Torbett issued a statement to extend "our condolences to the Royal Family" on behalf of the ABPI and the pharmaceutical industry in the UK.

“The Queen led a life of duty and service to the people of the UK & Commonwealth and was an inspirational figurehead for the UK around the world.

“She leaves behind an unmatched legacy of dignified leadership and our industry joins with the rest of the nation in mourning at this sad time.”

Company Chemists' Association said: "We heard with great sorrow the news of the death of Queen Elizabeth II. We pay tribute to Her Majesty’s dedication and tenacity throughout her reign, and extend profound admiration and gratitude for her service. Our thoughts are with the royal family and all those who are mourning."

The Queen, whose husband died last year, had been suffering from what Buckingham Palace had called "episodic mobility problems" since the end of last year, forcing her to withdraw from nearly all her public engagements.

Elizabeth was the 40th monarch in a royal line that followed Norman King William the Conqueror, who claimed the English throne in 1066 after defeating Anglo-Saxon ruler Harold II at the Battle of Hastings.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less